(NASDAQ: ZLAB) Zai Lab's forecast annual revenue growth rate of 38.02% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 130.42%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.85%.
Zai Lab's revenue in 2025 is $418,326,000.On average, 4 Wall Street analysts forecast ZLAB's revenue for 2025 to be $610,432,014,008, with the lowest ZLAB revenue forecast at $608,315,678,737, and the highest ZLAB revenue forecast at $613,639,601,602. On average, 4 Wall Street analysts forecast ZLAB's revenue for 2026 to be $833,769,927,343, with the lowest ZLAB revenue forecast at $775,591,859,900, and the highest ZLAB revenue forecast at $909,449,252,224.
In 2027, ZLAB is forecast to generate $1,164,533,279,366 in revenue, with the lowest revenue forecast at $1,144,014,264,510 and the highest revenue forecast at $1,185,052,294,222.